These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 20501643

  • 1. Sprouty-4 inhibits transformed cell growth, migration and invasion, and epithelial-mesenchymal transition, and is regulated by Wnt7A through PPARgamma in non-small cell lung cancer.
    Tennis MA, Van Scoyk MM, Freeman SV, Vandervest KM, Nemenoff RA, Winn RA.
    Mol Cancer Res; 2010 Jun; 8(6):833-43. PubMed ID: 20501643
    [Abstract] [Full Text] [Related]

  • 2. Antitumorigenic effect of Wnt 7a and Fzd 9 in non-small cell lung cancer cells is mediated through ERK-5-dependent activation of peroxisome proliferator-activated receptor gamma.
    Winn RA, Van Scoyk M, Hammond M, Rodriguez K, Crossno JT, Heasley LE, Nemenoff RA.
    J Biol Chem; 2006 Sep 15; 281(37):26943-50. PubMed ID: 16835228
    [Abstract] [Full Text] [Related]

  • 3. Restoration of Wnt-7a expression reverses non-small cell lung cancer cellular transformation through frizzled-9-mediated growth inhibition and promotion of cell differentiation.
    Winn RA, Marek L, Han SY, Rodriguez K, Rodriguez N, Hammond M, Van Scoyk M, Acosta H, Mirus J, Barry N, Bren-Mattison Y, Van Raay TJ, Nemenoff RA, Heasley LE.
    J Biol Chem; 2005 May 20; 280(20):19625-34. PubMed ID: 15705594
    [Abstract] [Full Text] [Related]

  • 4. Heterotrimeric G-protein, Gα16, is a critical downstream effector of non-canonical Wnt signaling and a potent inhibitor of transformed cell growth in non small cell lung cancer.
    Avasarala S, Bikkavilli RK, Van Scoyk M, Zhang W, Lapite A, Hostetter L, Byers JT, Heasley LE, Sohn JW, Winn RA.
    PLoS One; 2013 May 20; 8(10):e76895. PubMed ID: 24204697
    [Abstract] [Full Text] [Related]

  • 5. EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition.
    Sun M, Liu XH, Lu KH, Nie FQ, Xia R, Kong R, Yang JS, Xu TP, Liu YW, Zou YF, Lu BB, Yin R, Zhang EB, Xu L, De W, Wang ZX.
    Cell Death Dis; 2014 Jun 26; 5(6):e1298. PubMed ID: 24967960
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prostacyclin inhibits non-small cell lung cancer growth by a frizzled 9-dependent pathway that is blocked by secreted frizzled-related protein 1.
    Tennis MA, Van Scoyk M, Heasley LE, Vandervest K, Weiser-Evans M, Freeman S, Keith RL, Simpson P, Nemenoff RA, Winn RA.
    Neoplasia; 2010 Mar 26; 12(3):244-53. PubMed ID: 20234818
    [Abstract] [Full Text] [Related]

  • 8. Peroxisome proliferator-activated receptor-gamma (PPAR(gamma)) inhibits tumorigenesis by reversing the undifferentiated phenotype of metastatic non-small-cell lung cancer cells (NSCLC).
    Bren-Mattison Y, Van Putten V, Chan D, Winn R, Geraci MW, Nemenoff RA.
    Oncogene; 2005 Feb 17; 24(8):1412-22. PubMed ID: 15608671
    [Abstract] [Full Text] [Related]

  • 9. K-homology splicing regulatory protein (KSRP) promotes post-transcriptional destabilization of Spry4 transcripts in non-small cell lung cancer.
    Bikkavilli RK, Zerayesus SA, Van Scoyk M, Wilson L, Wu PY, Baskaran A, Tang K, Raheem S, Samuelson BA, Reddy NM, Reddy SP, Cool CD, Kosmider B, Avasarala S, Winn RA.
    J Biol Chem; 2017 May 05; 292(18):7423-7434. PubMed ID: 28275056
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sprouty4 mediates amphiregulin-induced down-regulation of E-cadherin and cell invasion in human ovarian cancer cells.
    So WK, Cheng JC, Liu Y, Xu C, Zhao J, Chang VT, Leung PC.
    Tumour Biol; 2016 Jul 05; 37(7):9197-207. PubMed ID: 26768617
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
    Gao LM, Zheng Y, Wang P, Zheng L, Zhang WL, Di Y, Chen LL, Yin XB, Tian Q, Shi SS, Xu SF.
    Am J Physiol Lung Cell Mol Physiol; 2019 May 01; 316(5):L918-L933. PubMed ID: 30628487
    [Abstract] [Full Text] [Related]

  • 15. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y, Li S, Li J, Wang D, Li Q.
    Cell Physiol Biochem; 2017 May 01; 42(4):1431-1446. PubMed ID: 28715819
    [Abstract] [Full Text] [Related]

  • 16. Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC.
    Ciaramella V, Sasso FC, Di Liello R, Corte CMD, Barra G, Viscardi G, Esposito G, Sparano F, Troiani T, Martinelli E, Orditura M, De Vita F, Ciardiello F, Morgillo F.
    J Exp Clin Cancer Res; 2019 Apr 26; 38(1):178. PubMed ID: 31027492
    [Abstract] [Full Text] [Related]

  • 17. SPRY4 suppresses proliferation and induces apoptosis of colorectal cancer cells by repressing oncogene EZH2.
    Guo J, Zhu H, Li Q, Dong J, Xiong W, Yu K.
    Aging (Albany NY); 2021 Apr 20; 13(8):11665-11677. PubMed ID: 33879635
    [Abstract] [Full Text] [Related]

  • 18. Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC).
    Zhao Q, Yue J, Zhang C, Gu X, Chen H, Xu L.
    Oncotarget; 2015 Oct 06; 6(30):29335-46. PubMed ID: 26336823
    [Abstract] [Full Text] [Related]

  • 19. TUSC3 accelerates cancer growth and induces epithelial-mesenchymal transition by upregulating claudin-1 in non-small-cell lung cancer cells.
    Feng S, Zhai J, Lu D, Lin J, Dong X, Liu X, Wu H, Roden AC, Brandi G, Tavolari S, Bille A, Cai K.
    Exp Cell Res; 2018 Dec 15; 373(1-2):44-56. PubMed ID: 30098333
    [Abstract] [Full Text] [Related]

  • 20. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3.
    Fan X, Wang Y, Jiang T, Cai W, Jin Y, Niu Y, Zhu H, Bu Y.
    Int J Mol Sci; 2018 May 16; 19(5):. PubMed ID: 29772705
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.